66 related articles for article (PubMed ID: 1327524)
1. Human small cell lung cancer expresses the octamer DNA-binding and nervous system-specific transcription factor N-Oct 3 (brain-2).
Schreiber E; Himmelmann A; Malipiero U; Tobler A; Stahel R; Fontana A
Cancer Res; 1992 Nov; 52(21):6121-4. PubMed ID: 1327524
[TBL] [Abstract][Full Text] [Related]
2. Primary brain tumors differ in their expression of octamer deoxyribonucleic acid-binding transcription factors from long-term cultured glioma cell lines.
Schreiber E; Merchant RE; Wiestler OD; Fontana A
Neurosurgery; 1994 Jan; 34(1):129-35. PubMed ID: 8121549
[TBL] [Abstract][Full Text] [Related]
3. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of the neuron restrictive silencer factor permits transcription of glycine receptor alpha1 subunit in small-cell lung cancer cells.
Gurrola-Diaz C; Lacroix J; Dihlmann S; Becker CM; von Knebel Doeberitz M
Oncogene; 2003 Aug; 22(36):5636-45. PubMed ID: 12944912
[TBL] [Abstract][Full Text] [Related]
5. NSP-encoded reticulons are neuroendocrine markers of a novel category in human lung cancer diagnosis.
van de Velde HJ; Senden NH; Roskams TA; Broers JL; Ramaekers FC; Roebroek AJ; Van de Ven WJ
Cancer Res; 1994 Sep; 54(17):4769-76. PubMed ID: 8062278
[TBL] [Abstract][Full Text] [Related]
6. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.
Westerman BA; Neijenhuis S; Poutsma A; Steenbergen RD; Breuer RH; Egging M; van Wijk IJ; Oudejans CB
Clin Cancer Res; 2002 Apr; 8(4):1082-6. PubMed ID: 11948117
[TBL] [Abstract][Full Text] [Related]
7. Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not on other lung carcinoma cell lines.
Teder P; Bergh J; Heldin P
Cancer Res; 1995 Sep; 55(17):3908-14. PubMed ID: 7543820
[TBL] [Abstract][Full Text] [Related]
8. Expression of vesicular monoamine transporters, synaptosomal-associated protein 25 and syntaxin1: a signature of human small cell lung carcinoma.
Graff L; Castrop F; Bauer M; Höfler H; Gratzl M
Cancer Res; 2001 Mar; 61(5):2138-44. PubMed ID: 11280778
[TBL] [Abstract][Full Text] [Related]
9. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation.
Gstaiger M; Georgiev O; van Leeuwen H; van der Vliet P; Schaffner W
EMBO J; 1996 Jun; 15(11):2781-90. PubMed ID: 8654375
[TBL] [Abstract][Full Text] [Related]
10. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.
Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M
Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339
[TBL] [Abstract][Full Text] [Related]
11. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma.
Strassheim D; Shafer SH; Phelps SH; Williams CL
Cancer Res; 2000 May; 60(10):2730-6. PubMed ID: 10825148
[TBL] [Abstract][Full Text] [Related]
12. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
Wang P; Branch DR; Bali M; Schultz GA; Goss PE; Jin T
Biochem J; 2003 Oct; 375(Pt 1):199-205. PubMed ID: 12841847
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of the 5'-flanking region of the human gastrin-releasing peptide gene in small cell lung carcinoma cell lines.
Nagalla SR; Spindel ER
Cancer Res; 1994 Aug; 54(16):4461-7. PubMed ID: 8044796
[TBL] [Abstract][Full Text] [Related]
14. N-Oct 5 is generated by in vitro proteolysis of the neural POU-domain protein N-Oct 3.
Atanasoski S; Schreiber E; Fontana A; Herr W
Oncogene; 1997 Mar; 14(11):1287-94. PubMed ID: 9178889
[TBL] [Abstract][Full Text] [Related]
15. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
[TBL] [Abstract][Full Text] [Related]
16. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
17. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor expression in human lung cancer cell lines.
Haeder M; Rotsch M; Bepler G; Hennig C; Havemann K; Heimann B; Moelling K
Cancer Res; 1988 Mar; 48(5):1132-6. PubMed ID: 2830015
[TBL] [Abstract][Full Text] [Related]
19. The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression.
Eisen T; Easty DJ; Bennett DC; Goding CR
Oncogene; 1995 Nov; 11(10):2157-64. PubMed ID: 7478537
[TBL] [Abstract][Full Text] [Related]
20. Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma.
Eymin B; Gazzeri S; Brambilla C; Brambilla E
Oncogene; 2001 Mar; 20(14):1678-87. PubMed ID: 11313916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
